SCHEMBL905260

SCHEMBL905260

NC1(O)C2CC3CC(C2)CC1(C(=O)O)C3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.42
CYP2C9 P11712 2/20 0.42
SLC6A4 P31645 1/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
NFKB1 P19838 1/20 0.36
STAT6 P42226 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SLC47A1 Q96FL8 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
POLB P06746 2/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28699821 0.79 THRB (0.36) THRBCYP2C9TSHRALDH1A1ALOX15
SCHEMBL31084436 0.78 THRB (0.35) THRBCYP2C9TSHRALDH1A1ALOX15
Hydrochloric Acid SCHEMBL11330577 0.77 THRB (0.40) THRBCYP2C9LMNATSHRSLC22A2
SCHEMBL4711516 0.76 THRB (0.34) THRBCYP2C9ALDH1A1EPHX1EPHX2
SCHEMBL5285298 0.76 THRB (0.39) THRBCYP2C9LMNATSHRSLC22A2
SCHEMBL4582380 0.75 EPHX2 (0.40) THRBCYP2C9ALDH1A1EPHX1EPHX2
SCHEMBL5248488 0.75 THRB (0.36) THRBCYP2C9ALDH1A1EPHX1EPHX2
Bromide SCHEMBL27511892 0.73 THRB (0.35) THRBCYP2C9ALDH1A1EPHX1EPHX2
Hydrochloric Acid SCHEMBL27525501 0.73 THRB (0.35) THRBCYP2C9ALDH1A1ALOX15EPHX1
SCHEMBL31084441 0.72 MAPK1 (0.36) THRBCYP2C9LMNANFKB1STAT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272825-B1 Protected amino hydroxy adamantane carboxylic acid and process for its preparation ASTRAZENECA AB (SE) 2015-11-04 EP claimed
WO-2013111158-A2 PROCESS FOR THE PREPARATION OF DPP-IV INHIBITOR MSN LABORATORIES LIMITED (IN) 2013-08-01 WO claimed
EP-2272825-A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation Bristol-Myers Squibb Company (US) 2011-01-12 EP claimed
EP-1559710-A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use Bristol-Myers Squibb Company (US) 2005-08-03 EP claimed
EP-2272825-B1 Protected amino hydroxy adamantane carboxylic acid and process for its preparation ASTRAZENECA AB (SE) 2015-11-04 EP disclosed
EP-2272825-B1 Protected amino hydroxy adamantane carboxylic acid and process for its preparation ASTRAZENECA AB (SE) 2015-11-04 EP disclosed
WO-2013111158-A2 PROCESS FOR THE PREPARATION OF DPP-IV INHIBITOR MSN LABORATORIES LIMITED (IN) 2013-08-01 WO disclosed
EP-2272825-A3 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation Bristol-Myers Squibb Company (US) 2011-05-04 EP disclosed
EP-2272825-A3 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation Bristol-Myers Squibb Company (US) 2011-05-04 EP disclosed
EP-2272825-A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation Bristol-Myers Squibb Company (US) 2011-01-12 EP disclosed